Pfizer/BioNTech seek FDA nod for new COVID boosters for children - 27 septembrie 2022

De la TradeVille.ro wiki


Pfizer Inc (US.PFE) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna (US.MRNA) also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11.


MORE DETAILS